Blog icon

The Immune Resilience Future Science Platform

The COVID-19 pandemic is accelerating our understanding of the immune systems in both humans and animals. The Immune Resilience Future Science Platform will focus on new and emerging science that will provide an even deeper understanding of these systems, so we can modulate and harness immune responses to diseases, enabling better protection and swifter responses to emerging health threats.

Visit our website to learn more

Zoonotic diseases

More than 70 per cent of emerging diseases are zoonotic in nature – passing from animals to people – such as SARS, MERS and COVID-19. Our unique expertise works to minimise the impact of costly infectious disease outbreaks.

Infectious diseases

Our unique expertise works to minimise the impact of costly infectious disease outbreaks.

COVID-19 research

We're involved in a broad range of activities with government and industry in response to COVID-19.

Australian Centre for Disease Preparedness 

ACDP (formerly known as the Australian Animal Health Laboratory) helps protect Australia’s multi-billion dollar livestock and aquaculture industries, and the general public, from emerging infectious disease threats. It is a high-containment facility designed to allow scientific research into the most dangerous infectious agents in the world.

Explore our disease research

Detecting Alzheimer's disease

We’re working to develop a non-invasive saliva test for the early detection of Alzheimer’s disease.

Improving access to CVD therapy

We're investigating the use of a mobile health platform to support Indigenous health.

e-cigarettes and health

We recently undertook a review into the use and health impacts of e-cigarettes and personal vaporisers.

Discovering ILRUN

Our ground-breaking work on Hendra virus led to the discovery of a potential genetic "off switch" for influenza, cancer, arthritis, and autoimmune disorders.

Detecting diabetic retinopathy

Helping to save the eyesight of people with diabetes, we've developed new AI technology to enable GPs to screen for diabetic retinopathy.

Peritoneal dialysis platform

We’ve developed and trialled a mobile health platform to support patients on peritoneal dialysis and their care team.

Gestational diabetes platform

We've developed and trialled a mobile health platform to help patients and clinicians better track and monitor gestational diabetes.

Patient care

CSIRO software predicts demands on hospital emergency departments to enhance patient care and resource management.

Knee replacement rehab app

We've developed a digital support platform to help patients prepare for and recover from total knee replacements.

Pain intervention app

We’ve teamed up with Metro North Hospital and Health Service and the University of Queensland to develop a mobile platform for pain intervention.

Cutting hospital waiting times

Using software developed by our scientists, hospitals can predict how many patients will arrive in emergency and how many will be admitted or discharged.

Vector-borne diseases

Our scientists are studying mosquitoes and other insects that carry and transmit disease causing viruses. This will help improve our knowledge on the viruses they carry, how they develop immunity against them and how to best prevent or manage these human and animal health threats.

Disease-carrying insects

Our scientists are studying disease-carrying mosquitoes and other insects to understand what viruses they carry, how they develop immunity to the diseases they carry and how they transmit disease throughout the environment.

Mosquito research

Our scientists are studying mosquitoes and the diseases they carry to investigate ways to reduce their impact on our health.

Dengue-resistant mosquitoes

In partnership with the University of California San Diego, we've engineered and tested the first breed of genetically modified mosquitoes resistant to spreading all four types of the dengue virus.

New technologies

We’ve teamed up with Verily and James Cook University on Debug Innisfail, a project studying new technologies to reduce the population of the invasive Aedes aegypti mosquito that can spread dengue and Zika.

Japanese encephalitis

Japanese encephalitis (JE) virus is a potentially fatal disease that infects about 100,000 people worldwide every year. Caused by an arbovirus (an arthropod-borne virus), it is transmitted by mosquitoes.

Infectious Disease Resilience

Working with partners, we aim to enhance the Indo-Pacific region's ability to detect - and respond to - infectious disease threats by 2030.

Contact us

Find out how we can help you and your business. Get in touch using the form below and our experts will get in contact soon!

CSIRO will handle your personal information in accordance with the Privacy Act 1988 (Cth) and our Privacy Policy.


First name must be filled in

Surname must be filled in

I am representing *

Please choose an option

Please provide a subject for the enquriy

0 / 100

We'll need to know what you want to contact us about so we can give you an answer

0 / 1900

You shouldn't be able to see this field. Please try again and leave the field blank.